×
Novo Integrated Sciences Receivables 2012-2024 | NVOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Novo Integrated Sciences receivables from 2012 to 2024. Receivables can be defined as the total amount of collectibles for a company
View More
Novo Integrated Sciences Receivables 2012-2024 | NVOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Novo Integrated Sciences receivables from 2012 to 2024. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$21.4B
Quest Diagnostics (DGX)
$17.3B
DaVita (DVA)
$13.7B
Encompass Health (EHC)
$9.3B
Chemed (CHE)
$8.7B
Elanco Animal Health (ELAN)
$7.2B
Option Care Health (OPCH)
$5.3B
RadNet (RDNT)
$5B
Amedisys (AMED)
$3.2B
Astrana Health (ASTH)
$2.8B
LifeStance Health (LFST)
$2.6B
Addus HomeCare (ADUS)
$2.4B
U.S Physical Therapy (USPH)
$1.3B
Pennant (PNTG)
$1.1B
Aveanna Healthcare Holdings (AVAH)
$1B
Atai Life Sciences (ATAI)
$208M
Daxor (DXR)
$45M
ATI Physical Therapy (ATIP)
$25M
MEDIROM Healthcare Technologies (MRM)
$19M
Psychemedics (PMD)
$14M
Ontrak (OTRK)
$10M
IMAC Holdings (BACK)
$2M